Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China flag China · Delayed Price · Currency is CNY
18.58
-0.08 (-0.43%)
At close: Mar 18, 2026

SHE:000623 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
21,78320,65317,09817,02021,03418,957
Market Cap Growth
9.14%20.79%0.46%-19.09%10.96%-1.39%
Enterprise Value
21,16920,12616,96117,19319,59617,652
Last Close Price
18.5816.8013.9113.5216.3314.37
PE Ratio
8.5313.3111.719.5611.8111.09
PS Ratio
9.307.914.965.939.138.42
PB Ratio
0.710.710.620.650.840.81
P/TBV Ratio
0.720.720.640.660.860.82
P/FCF Ratio
169.18--111.321821.95116.28
P/OCF Ratio
81.46347.21251.2240.1564.7548.56
EV/Sales Ratio
9.047.714.925.998.517.84
EV/EBITDA Ratio
252.52442.5449.9152.6697.79136.07
EV/EBIT Ratio
--126.08132.353339.39-
EV/FCF Ratio
164.41--112.451697.40108.28
Debt / Equity Ratio
0.070.080.110.110.100.11
Debt / EBITDA Ratio
26.8031.378.238.4112.4519.13
Debt / FCF Ratio
17.45--19.56226.5815.22
Net Debt / Equity Ratio
-0.03-0.01-0.01-0.03-0.08-0.09
Net Debt / EBITDA Ratio
-15.31-8.49-1.02-2.68-10.08-15.66
Net Debt / FCF Ratio
-6.701.800.99-5.73-174.93-12.46
Asset Turnover
0.070.080.110.100.080.09
Inventory Turnover
1.391.772.021.931.951.70
Quick Ratio
1.761.571.082.253.894.01
Current Ratio
2.141.961.292.704.354.47
Return on Equity (ROE)
8.51%5.35%5.37%7.01%7.29%7.36%
Return on Assets (ROA)
-0.28%-0.31%0.27%0.27%0.01%-0.15%
Return on Invested Capital (ROIC)
-0.50%-0.57%0.49%0.54%0.03%-0.31%
Return on Capital Employed (ROCE)
-0.50%-0.50%0.50%0.40%0.00%-0.30%
Earnings Yield
11.79%7.51%8.54%10.46%8.46%9.01%
FCF Yield
0.59%-1.04%-2.06%0.90%0.06%0.86%
Dividend Yield
2.68%2.98%4.31%2.22%1.84%1.39%
Payout Ratio
25.49%68.33%27.44%21.21%14.36%14.76%
Buyback Yield / Dilution
7.34%9.08%0.46%-3.36%1.39%0.28%
Total Shareholder Return
10.02%12.06%4.77%-1.14%3.22%1.67%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.